Raja links PM to all key 2G decisions

April 23, 2013

Raja_links_PMNew Delhi, April 23: In his 112-page written statement to the Joint Parliamentary Committee (JPC) probing the 2G scam, the former Telecom Minister and prime accused, A. Raja, has said he personally met Prime Minister Manmohan Singh severalspectrum allocation times between November 2007 and July 2008 — the period when the scam was perpetrated — to keep him informed of all 2G-related decisions, and the Prime Minister agreed with him.

On Page 72, while challenging the JPC’s draft report and the CBI’s allegations that Mr. Raja had “misled” the Prime Minister, he says: “This allegation has been made by the CBI without even recording the statement of the Hon’ble PM. On what basis do they say he was misled? I hope the JPC will not commit the same blunder; if they wish to draw any conclusion on this issue, it is mandatory to record my statement and the statement of the Hon’ble PM.” But the draft report has already reached that conclusion.

Mr. Raja then goes on to give details of his meetings, letters and conversations with the Prime Minister, several of which are not in the public domain.

Mr. Raja claims that apart from seven letters between November 2, 2007, and July 2, 2010, “I had several personal discussions with the Hon’ble PM on telecom issues throughout my tenure and particularly in the period from November 2007–January 2008.” He further provides occasions and venues where such meetings took place. “These would happen on the side of Cabinet meetings or separately at his office/residence.”

The Prime Minister has made specific statements on his discussions with Mr. Raja at a TV Editors press conference and in Parliament in February 2011, but has not disclosed either the occurrence or the details of these meetings, save one held among Mr. Raja, Mr. Chidambaram, and himself on July 4, 2008, seven months after the scam broke out.

Met PM a week before scam

Mr. Raja says that after his December 26, 2007 letter, which detailed the change in the first-come first-served (FCFS) policy, “I met the Hon’ble PM in the first week of January 2008, and this issue was again discussed, and he agreed with the proposed course of action of the DoT.” If correct, the meeting would have occurred within a week prior to the award of Letters of Intent for 2G licences on January 10, 2008, and supports documents that show that on the Prime Minister’s request of December 29, 2007, Pulok Chatterji, Secretary, and T.K.A. Nair, Principal Secretary to the Prime Minister, had discussed and endorsed Mr. Raja’s modification of the FCFS policy in PMO files through notings on 1, 6 and 7, January 2008. This was highlighted in a news report, ‘New papers show PMO analysed and agreed with Raja’s actions before 2G scam,’ published in The Hindu on March 18, 2013.

Continuing with his attack on the contention that the Prime Minister was misled, Mr. Raja says: “DoT officers were in touch with PMO regularly, without even involving me, as seen by the file notings of the PMO itself.” On July 24, 2012, CBI officials deposed before the JPC that they had not gone through the PMO files. The CBI stated that it approached a “Section Officer” in the PMO to check the “authenticity” of certain documents.

In the statement, Mr. Raja details instances and the importance of his face-to-face meetings with the Prime Minister and the then Law Minister, H.R. Bhardwaj, whose advice to take the 2G spectrum issue to the Empowered Group of Ministers (eGoM), had been rejected by Mr. Raja as “totally out of context.”

Citing “several interactions” he had with the Prime Minister and the Law Minister, he says: “If either of them had desired that the eGoM should consider this matter, they would have told me and I would have acted accordingly. However, neither of them ever made this suggestion, and rather they fully understood and endorsed my course of action.”

Pointing to his re-appointment as Telecom Minister after the 2009 election, Mr. Raja says: “…surely if he [the Prime Minister] felt that I misled him or offended him in any manner, my appointment would not have happened.”

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
June 12,2020

An Indian national was killed and four others injured in alleged firing by Nepal police personnel along the India-Nepal border in Bihar's Sitamarhi district today.

Sources said the firing took place after a clash between the Indians and personnel of Nepal police at the Lalbandi-Janki Nagar border in Pipra Parsain panchayat under Sonebarsha police station of the district.

Jitendra Kumar, the additional director general of police (headquarters), confirmed the death and injuries. The place of firing falls under Nepal jurisdiction.

Locals said Vikesh Kumar Rai, 25, died on the spot and Umesh Ram and Uday Thakur received bullet injuries when they were working in an agricultural field. Another person, Lagan Rai, is said to have been detained by the Nepali police.

Injured persons were rushed to Sitamarhi Sadar Hospital for better treatment.

Vikesh Kumar Rai’s father, Nageshwar Rai, said that his agriculture land falls under Narayanpur in Nepal where his son was working.

On May 17, Nepal police had fired blank rounds to disperse dozens of Indians trying to cross the border. It was not clear if they were also farmers.

The district magistrate and the superintendent of police of Sitamarhi have rushed to the spot.

Nepal shares a 1,850-kilometre (1,150-mile) open border with India and people travel across it for work and to visit family. It had closed its international borders on March 22 amid the coronavirus pandemic.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
March 24,2020

New Delhi, Mar 24: Thirty-two states and Union Territories (UTs) have announced complete lockdown to check the spread of the coronavirus in the country, informed the Central government on Tuesday.
There is a complete lockdown in as many as 560 districts of the country affecting several hundred million people.
Earlier, the complete lockdown was imposed in 30 districts, as of now, almost the entire country is in lockdown to restrict public movement in an attempt to break the chain of transmission of coronavirus.
Three states -- Uttar Pradesh, Madhya Pradesh and Odisha -- have announced lockdown in select districts with the governments continuously monitoring the situation and ready to extend the restrictions to other districts as well.
The Union Territory of Lakshadweep has announced restrictions on certain activities.
The Indian Railways has suspended all passenger train operations till March 31 in view of coronavirus.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
August 3,2020

The Drugs Controller General of India (DCGI) has given nod to the Serum Institute of India (SII) for conducting phase 2 and 3 human clinical trials of the Oxford University developed Covid-19 vaccine candidate in the country.

Government officials said that the approval for conducting phase 2 and 3 clinical trials by the SII was granted by DCGI Dr V G Somani late Sunday night after a thorough evaluation based on the recommendations of the Subject Expert Committee (SEC) on Covid-19.

"The firm has to submit safety data, evaluated by the Data Safety Monitoring Board (DSMB), to the CDSCO before proceeding to phase 3 clinical trials," a senior official said.

"As per the study design, each subject will be administered two doses four weeks apart (first dose on day one and second dose on day 29) following which the safety and immunogenicity will be assessed at predefined intervals," the official said.

As a rapid regulatory response, the expert panel at the Central Drugs Standard Control Organisation (CDSCO) on Friday, after a detailed deliberation and considering the data generated on the vaccine candidate in phase 1 and 2 of the Oxford University trial, had recommended granting permission for phase 2 and 3 clinical trials of the potential vaccine, 'Covishield', on healthy adults in India,  the officials said.

Currently, phase 2 and 3 clinical trials of the Oxford vaccine candidate is going on in the United Kingdom, phase 3 clinical trial in Brazil and phase 1 and 2 clinical trials in South Africa.

The officials said that the SII had submitted a revised proposal on Wednesday after the SEC on July 28, following deliberation over its application, had asked it to revise its protocol for the phase 2 and 3 clinical trials besides seeking some additional information.

The panel had also recommended that the clinical trial sites which have been proposed for the study be distributed across India.

According to the revised proposal by the SII, 1,600 people aged above 18 years will participate in the trials across 17 selected sites, including AIIMS-Delhi, B J Medical College in Pune, Rajendra Memorial Research Institute of Medical Sciences (RMRIMS) in Patna, Post Graduate Institute of Medical Education and Research in Chandigarh, AIIMS-Jodhpur, Nehru Hospital in Gorakhpur, Andhra Medical College in Visakhapatnam and JSS Academy of Higher Education and Research in Mysore.

"According to the application, it would conduct an observer-blind, randomised controlled study to determine the safety and immunogenicity of 'Covishield' on healthy Indian adults," the official said.

The SII, which has partnered with AstraZeneca, for manufacturing the Oxford vaccine candidate for Covid-19 had submitted its first application to the DCGI on July 25 seeking permission for conducting the phase 2 and 3 trials of the potential vaccine. 

Initial results of the first two-phases of trials of the vaccine conducted in five trial sites in the UK showed that it has an acceptable safety profile and homologous boosting increased antibody response, sources had said.

To introduce the vaccine, SII, the world's largest vaccine maker by number of doses produced and sold, has signed an agreement to manufacture the potential vaccine developed by the Jenner Institute (Oxford University) in collaboration with British-Swedish pharma company AstraZeneca. 

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.